| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A critical role for GM1 ganglioside in the pathophysiology and potential treatment of Parkinson’s disease
|
Schneider, J. S.
|
|
|
39 |
1 |
p. 13-26
|
article
|
| 2 |
A galacturonan from Dioscorea opposita Thunb. regulates fecal and impairs IL-1 and IL-6 expression in diarrhea mice
|
Pan, Hao-Yu
|
|
|
39 |
1 |
p. 131-141
|
article
|
| 3 |
Glycoconjugate journal special issue on: the glycobiology of Parkinson’s disease
|
Brockhausen, Inka
|
|
|
39 |
1 |
p. 55-74
|
article
|
| 4 |
Glycosphingolipid metabolism and its role in ageing and Parkinson’s disease
|
Wallom, Kerri-Lee
|
|
|
39 |
1 |
p. 39-53
|
article
|
| 5 |
Innovative treatment targeting gangliosides aimed at blocking the formation of neurotoxic α-synuclein oligomers in Parkinson’s disease
|
Yahi, Nouara
|
|
|
39 |
1 |
p. 1-11
|
article
|
| 6 |
Novel insights on GM1 and Parkinson's disease: A critical review
|
Fazzari, Maria
|
|
|
39 |
1 |
p. 27-38
|
article
|
| 7 |
Plasma membrane glycosphingolipid signaling: a turning point
|
Chiricozzi, Elena
|
|
|
39 |
1 |
p. 99-105
|
article
|
| 8 |
Protective Effects of a synthetic glycosaminoglycan mimetic (OTR4132) in a rat immunotoxic lesion model of septohippocampal cholinergic degeneration
|
Pereira, Patricia Marques
|
|
|
39 |
1 |
p. 107-130
|
article
|
| 9 |
Systemic deficiency of GM1 ganglioside in Parkinson’s disease tissues and its relation to the disease etiology
|
Ledeen, Robert
|
|
|
39 |
1 |
p. 75-82
|
article
|
| 10 |
35 years in plant lectin research: a journey from basic science to applications in agriculture and medicine
|
Van Damme, Els J. M.
|
|
|
39 |
1 |
p. 83-97
|
article
|
Journal description